Boucly et al. [18] proposed three noninvasive criteria (WHO/NYHA functional class, 6MWD and BNP/NTproBNP) for the accurate prognosis predictions in PAH patients. This evidence concerns the gene NPPB and pulmonary arterial hypertension.